This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
Portfolio Pulse from Avi Kapoor
Jim Cramer, on CNBC's 'Mad Money Lightning Round,' labeled Camtek Ltd. as 'too expensive' and advised waiting for a pullback. He expressed a longstanding dislike for Novavax, Inc., preferring Nucor Corporation over Atkore Inc. for steel-related investments. Cramer also deemed Coinbase Global, Inc. as 'too expensive' and suggested caution with EyePoint Pharmaceuticals, Inc. as 'the easy money has been made.' He compared American Eagle Outfitters, Inc. favorably to Abercrombie & Fitch Co., which he considers 'much better.'
December 08, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cramer prefers Nucor Corporation over Atkore Inc. for steel investments, which could sway investors towards Nucor.
Cramer's preference for Nucor Corporation as the 'best in show' for steel investments may divert investor interest away from Atkore Inc., potentially affecting ATKR's stock price negatively in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Jim Cramer called Camtek Ltd. 'too expensive' and suggested waiting for a pullback, indicating a potential overvaluation at its current price.
Cramer's comments may lead investors to believe that CAMT is overvalued, potentially causing a short-term decrease in stock price as investors may wait for a lower price before buying.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Cramer's concern about Coinbase Global, Inc. being 'too expensive' suggests the stock might be overvalued at its current level.
Cramer's advice to 'let it come in' implies that COIN's stock price might be too high, which could lead to a short-term negative impact as investors may hold off on purchasing until a price drop occurs.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Cramer believes that 'the easy money has been made' with EyePoint Pharmaceuticals, Inc., indicating a potential slowdown in its stock momentum.
Cramer's comment about EyePoint Pharmaceuticals could lead investors to believe that the stock's high-growth phase is over, potentially causing a short-term dip in its stock price as investors seek other opportunities.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Jim Cramer has a longstanding dislike for Novavax, Inc., which could influence investor sentiment negatively.
Cramer's negative opinion on NVAX, especially given its past higher valuation, may contribute to a bearish outlook among investors, possibly leading to a short-term price decline.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
Cramer views American Eagle Outfitters, Inc. as good but has a preference for Abercrombie & Fitch Co., which could influence investor preference.
While Cramer's comments are positive for American Eagle, his stronger recommendation for Abercrombie & Fitch Co. could neutralize the impact on AEO's stock price in the short term.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Cramer's preference for Abercrombie & Fitch Co. over American Eagle Outfitters, Inc. could positively impact ANF's stock.
Cramer's endorsement of Abercrombie & Fitch as 'much better' than American Eagle could lead to increased investor interest in ANF, possibly resulting in a short-term uptick in its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Cramer's recommendation of Nucor Corporation as the top choice for steel investments could boost investor confidence in NUE.
Cramer's preference for Nucor Corporation, referring to it as 'best in show,' may attract investors to NUE, potentially leading to a short-term increase in its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80